Evidence map›Paper›PMID 42488556›Full record

ArticleFrontiers in cell and developmental biology2026

TAF7 accumulates in the cytoplasm during cellular transformation and engages STAT3, WASH, and CCT.

Dan Cheng, Elizabeth McManus, Ryan M Young, Thomas Oellerich, Bjorn Haupl, Daniel D Billadeau, Hua Tan, Laura Elnitski, Dinah S Singer

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dan ChengExperimental Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Elizabeth McManusExperimental Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Ryan M YoungLymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Thomas OellerichDepartment of Medicine, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Frankfurt, Germany.
Bjorn HauplDepartment of Medicine, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Frankfurt, Germany.
Daniel D BilladeauDivision of Oncology Research, Mayo Clinic College of Medicine, Rochester, MN, United States.
Hua TanTranslational and Functional Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, United States.
Laura ElnitskiTranslational and Functional Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, United States.
Dinah S SingerExperimental Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TAF7, a core subunit of the general transcription factor TFIID, regulates transcription and additionally functions as an RNA chaperone that directs nascent nuclear RNAs to cytoplasmic polysomes, thereby influencing protein synthesis. Here, we identify a set of novel cytoplasmic interactors and a previously unappreciated cytoplasmic role for TAF7 in oncogenesis. BioID-mediated proximity labeling identified STAT3 and the CCT and WASH complexes as prominent cytoplasmic interactors of TAF7. These interactions were validated by co-immunoprecipitation and proximity ligation assays. We further showed that cytoplasmic TAF7 levels increased during oncogenesis in proportion to cancer cell pathogenicity. Notably, TAF7 engagement with STAT3, CCT and WASH complexes is markedly enhanced during cellular transformation, consistent with their functions in cancer progression. Together, these findings reveal a cytoplasmic TAF7 interactome and implicate elevated cytoplasmic TAF7 as associated with oncogenesis.

Indexed as

CCTcytoplasmic TAF7oncogenesisSTAT3transformationWASH

Identifiers

PMID42488556
PMCPMC13388811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.